Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPN | P05981 | 1/20 | 0.59 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9823913 | 0.85 | HPN (0.52) | HPNSCN2AMEN1KMT2AMAPT | |
| SCHEMBL2510494 | 0.80 | AR (0.52) | MEN1KMT2AMAPTALDH1A1AR | |
| SCHEMBL10854270 | 0.80 | HPN (0.68) | HPNSCN2AMEN1KMT2AMAPT | |
| SCHEMBL2275042 | 0.79 | ALDH1A1 (0.59) | MEN1KMT2AALDH1A1AR | |
| SCHEMBL13689506 | 0.79 | AR (0.51) | MEN1KMT2AMAPTALDH1A1AR | |
| SCHEMBL10855612 | 0.77 | ALDH1A1 (0.51) | MEN1KMT2AALDH1A1AR | |
| SCHEMBL6140131 | 0.77 | HPN (0.64) | HPNSCN2AMEN1KMT2AMAPT | |
| SCHEMBL11273574 | 0.75 | HPN (0.57) | HPNSCN2AMEN1KMT2AMAPT | |
| SCHEMBL10429499 | 0.75 | MAPT (0.62) | HPNSCN2AMEN1KMT2AMAPT | |
| SCHEMBL3868871 | 0.75 | HPN (0.60) | HPNSCN2AMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110245242-A1 | Heterocyclically Substituted Anilinopyrimides | BAYER CROPSCIENCE AG (DE) | 2011-10-06 | — | — | US | disclosed |
| CN-102203080-A | Heterocyclically substituted anilinopyrimidines as fungicides | BAYER CROPSCIENCE AG | 2011-09-28 | — | — | CN | disclosed |
| EP-2331524-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | Bayer CropScience AG (DE) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010025831-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | disclosed |
| US-4595408-A | N-m-phenyl succinimide and glutarimide derivatives and their use as herbicides | STAUFFER CHEMICAL CO. (US) | 1986-06-17 | — | — | US | disclosed |
| US-4400202-A | N-m-Phenyl glutarimide derivatives and their use as herbicides | STAUFFER CHEMICAL COMPANY (US) | 1983-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245242-A1 | Heterocyclically Substituted Anilinopyrimides | H1-10, POLL, PPM1D | HPN 2683/4885SCN2A 2408/4885MEN1 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.